Immediate Impact
2 by Nobel laureates 3 from Science/Nature 53 standout
Citing Papers
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
2024 Standout
Targeting KRAS in cancer
2024 Standout
Works of Archie Thurston being referenced
Abstract CT006: First-in-class, first-in-human phase 1 trial of VT3989, an inhibitor of yes-associated protein (YAP)/transcriptional enhancer activator domain (TEAD), in patients (pts) with advanced solid tumors enriched for malignant mesothelioma and other tumors with neurofibromatosis 2 (NF2) mutations
2023
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Archie Thurston | 162 | 122 | 57 | 72 | 18 | 472 | |
| Lewis J. Klunk | 158 | 88 | 26 | 119 | 25 | 448 | |
| Mukul Minocha | 139 | 241 | 81 | 48 | 32 | 574 | |
| Yiding Hu | 119 | 93 | 64 | 65 | 22 | 452 | |
| Bas Thijssen | 137 | 202 | 70 | 58 | 21 | 451 | |
| I. Gardner | 132 | 101 | 29 | 193 | 15 | 500 | |
| Hisakazu Komori | 232 | 113 | 31 | 42 | 26 | 520 | |
| Daria Stypinski | 78 | 164 | 39 | 123 | 29 | 548 | |
| David F. Gebhard | 220 | 143 | 16 | 61 | 12 | 529 | |
| Fabienne Z. Gaugaz | 206 | 157 | 23 | 67 | 13 | 457 | |
| Remco L.A. de Vrueh | 173 | 78 | 27 | 18 | 17 | 507 |
All Works
Loading papers...